Is It Possible to Treat Diseases by Metals? |
| H. Sakurai and M. Chikuma |
| J. Pharm. Soc. Jpn., 128(3), 305-306, 2008 |
|
Current Status and Future Perspectives of Platinum Antitumor Drugs |
| M. Chikuma, T. Sato, and S. Komeda |
| J. Pharm. Soc. Jpn., 128(3), 307-316, 2008 |
|
Treatment of Diabetes in Experimental Animals by Metallocomplexes |
| H. Sakurai |
| J. Pharm. Soc. Jpn., 128(3), 317-322, 2008 |
|
Application of Radiometallic Compounds for Medical Diagnosis and Therapy |
| H. Saji |
| J. Pharm. Soc. Jpn., 128(3), 323-332, 2008 |
|
Zinc Deficiency and Clinical Practice—Validity of Zinc Preparations— |
| H. Yanagisawa |
| J. Pharm. Soc. Jpn., 128(3), 333-339, 2008 |
|
A Gathering of Young Generation for Future Atherosclerosis Research—New Development by Interactions among Young Researchers in Different Fields— |
| M. Ueda |
| J. Pharm. Soc. Jpn., 128(3), 341-342, 2008 |
|
Functional Analysis of Nuclear Receptor Farnesoid X Receptor Controlling Metabolism of Cholesterol |
| M. Ohno |
| J. Pharm. Soc. Jpn., 128(3), 343-355, 2008 |
|
Effect of Pitavastatin on Macrophage Cholesterol Metabolism |
| Y. Akisato, I. Ishii, M. Kitahara, T. Tamaki, Y. Saito, M. Kitada |
| J. Pharm. Soc. Jpn., 128(3), 357-363, 2008 |
|
Proteoglycan as a Key Molecule in Atherosclerosis Progression: Characteristics of the Structure and Regulation of the Synthesis |
| A. Urano, C. Yamamoto, Y. Fujiwara, and T. Kaji |
| J. Pharm. Soc. Jpn., 128(3), 365-375, 2008 |
|
The Role of Thrombospondin-1 in Hypoxia-induced Migration of Human Vascular Smooth Muscle Cells |
| M. Takahashi, M. Oka, T. Ikeda, S. Akiba, and T. Sato |
| J. Pharm. Soc. Jpn., 128(3), 377-383, 2008 |
|
The Variance of the Expressions of Extracellular Matrix Components and the Effects of the Anti-Osteoporotic Drugs on Mönckeberg's Arteriosclerosis |
| E. Saitoh, Y. Nagae, H. Wachi, and Y. Seyama |
| J. Pharm. Soc. Jpn., 128(3), 385-392, 2008 |
|
Drug Development Using Novel Pharmacological Evaluation |
| N. Shioda and Y. Zamami |
| J. Pharm. Soc. Jpn., 128(3), 393-393, 2008 |
|
Involvement of the Amygdala on Place Aversion Induced by Naloxone in Single-Dose Morphine-Treated Rats |
| S. Ishida, R. Shimosaka, Y. Kawasaki, C. Jin, Y. Kitamura, H. Araki, T. Sendo, and Y. Gomita |
| J. Pharm. Soc. Jpn., 128(3), 395-403, 2008 |
|
Psychological Stress-induced Changes in Sleep Patterns and Its Generation Mechanism |
| R. Cui, B. Li, K. Suemaru, and H. Araki |
| J. Pharm. Soc. Jpn., 128(3), 405-411, 2008 |
|
Vanadium Compounds Enhance Adult Neurogenesis after Brain Ischemia |
| N. Shioda, M. Morioka, and K. Fukunaga |
| J. Pharm. Soc. Jpn., 128(3), 413-417, 2008 |
|
Effect of Postprandial Hyperglycemia and Hyperinsulinemia on Vascular Responsiveness |
| Y. Zamami, S. Takatori, Y. Iwatani, K. Yamawaki, S. Miyashita, N. Yabumae, F. Takayama, M. Mio, and H. Kawasaki |
| J. Pharm. Soc. Jpn., 128(3), 419-424, 2008 |
|
Gastro-retentive Dosage Form for Improving Bioavailability of Cefpodoxime Proxetil in Rats |
| V. K. Kakumanu, V. K. Arora, and A. K. Bansal |
| J. Pharm. Soc. Jpn., 128(3), 439-445, 2008 |
|
Evaluation of the 2.5 mg Fentanyl Patch, Applied Using the Half-side Application Procedure in Patients with Cancer Pain |
| H. Kokubun, M. Matoba, M. Okazaki, S. Hoka, and K. Yago |
| J. Pharm. Soc. Jpn., 128(3), 447-450, 2008 |
|
The Clinical Efficacy of Kanamycin for Mycobacterium avium Complex Disease |
| A. Suzuki, T. Nishimura, S. Ohtawa, J. Mikami, A. Kurashima, M. Saito, and M. Mita |
| J. Pharm. Soc. Jpn., 128(3), 451-460, 2008 |
|
Effect of Panax ginseng Components on the Differentiation of Mouse Embryonic Stem Cells into Cardiac-like Cells |
| T. Sasaki, K.-B. Oh, H. Matsuoka, and M. Saito |
| J. Pharm. Soc. Jpn., 128(3), 461-467, 2008 |
|
Reduction of Ischemic, Pharmacological and Remote Preconditioning Effects by an Antioxidant N-Acetyl Cysteine Pretreatment in Isolated Rat Heart |
| G. Khanna, V. Diwan, M. Singh, N. Singh, and A. S. Jaggi |
| J. Pharm. Soc. Jpn., 128(3), 469-477, 2008 |
|
Bitterness of the Mixture of Clarithromycin Dry Syrup and Carbocisteine Preparation-difference between Branded and Generic Drugs |
| R. Matsuo, S. Tanaka, M. Kanou, K. Isono, Y. Tanaka, T. Taura, Y. Asada, Y. Akamine, H. Sawai, M. Kinosita, T. Sudou, Y. Kunoki, A. Miki, S. Hori, H. Satoh, H. Ohtani, and Y. Sawada |
| J. Pharm. Soc. Jpn., 128(3), 479-485, 2008 |
|